Opeolu Adeoye, MD, MS

Articles by Opeolu Adeoye, MD, MS

Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS

Efficacy of Adjunctive Therapies for Acute Ischemic Stroke Based on Phase 3 MOST Trial: Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS

ByOpeolu Adeoye, MD, MS,Andrew Barerrto, MD, MS

February 26th 2024

The professor of emergency medicine at Washington University in St. Louis and associate professor of neurosurgery at UTHealth Houston talked about results from the phase 3 MOST trial assessing argatroban and eptifibatide in acute ischemic stroke. [WATCH TIME: 3 minutes]

Latest Updated Articles

FDA Approves Lecanemab Autoinjector, Marking First At-Home Treatment for Alzheimer Disease
Published: August 29th 2025 | Updated: September 2nd 2025
Indirect Comparison Study Hints at Lower ARIA and ICH-Related Mortality Risk in Lecanemab Over Donanemab
Published: July 28th 2025 | Updated: July 30th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Published: May 14th 2025 | Updated: May 16th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
Published: May 12th 2025 | Updated: May 13th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025

Trending on NeurologyLive

Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update

EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits

Current Challenges and New Opportunities Ahead for Women in Neurology

Managing Dyskinesia Through Continuous Infusion Therapy

2025 Women in Neurology Conference: Educating, Mentoring, and Networking

© 2025 MJH Life Sciences^®

All rights reserved.